Related Experiment Videos
[Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines]
Abstract:
Partially purified water-soluble cellular protein antigens have been obtained from 2 newly isolated P. aeruginosa strains and 1 museum P. aeruginosa strain, belonging to immunotypes 2, 3 and 7, by the method of preparative ultracentrifugation. Such trivalent P. aeruginosa vaccine (PV) has proved to be effective in direct and cross experiments of the active protection of mice. The method of ultrafiltration has been used to prepare monovalent PV from a newly isolated strain belonging to immunotype 3/7. This monovalent PV has been found to stimulate immunity to infection with homologous or heterologous P. aeruginosa strains in mice. The comparison of the results obtained in the study of PV prepared by the methods of ultracentrifugation and ultrafiltration suggests that both these methods for the isolation and purification of P. aeruginosa protective protein antigens are equally effective.
Insights
Researchers developed effective Pseudomonas aeruginosa vaccines (PV) using ultracentrifugation and ultrafiltration. Both methods successfully isolated protective protein antigens, demonstrating equal efficacy in protecting mice against P. aeruginosa infections.
Area of Science:
- Microbiology and Immunology
- Vaccine Development
- Bacterial Pathogenesis
Background:
- Pseudomonas aeruginosa is an opportunistic pathogen causing severe infections, particularly in immunocompromised individuals.
- Effective vaccines are crucial for preventing and controlling P. aeruginosa infections.
- Identifying and purifying protective antigens is key to vaccine development.
Purpose of the Study:
- To isolate and purify water-soluble cellular protein antigens from P. aeruginosa strains.
- To evaluate the efficacy of vaccines prepared using ultracentrifugation and ultrafiltration.
- To assess the protective immunity conferred by monovalent and trivalent P. aeruginosa vaccines.
Main Methods:
- Preparative ultracentrifugation was used to obtain partially purified protein antigens from P. aeruginosa strains of immunotypes 2, 3, and 7.
- Ultrafiltration was employed to prepare a monovalent vaccine from a strain of immunotype 3/7.
- Active protection experiments in mice were conducted to assess vaccine efficacy against homologous and heterologous P. aeruginosa strains.
Main Results:
- A trivalent P. aeruginosa vaccine (PV) prepared by ultracentrifugation demonstrated effectiveness in protecting mice.
- A monovalent PV prepared by ultrafiltration stimulated immunity against P. aeruginosa infection in mice.
- Both ultracentrifugation and ultrafiltration proved equally effective for isolating and purifying protective P. aeruginosa protein antigens.
Conclusions:
- Partially purified water-soluble protein antigens from P. aeruginosa can be effectively isolated using preparative ultracentrifugation and ultrafiltration.
- Both trivalent and monovalent P. aeruginosa vaccines derived from these antigens confer protection in mice.
- Ultracentrifugation and ultrafiltration are equally effective methods for producing P. aeruginosa protective protein antigens for vaccine development.